European industry failed to leverage the digital revolution across multiple sectors and global competition has been chipping away at the Continent's wealth and security : existential choices for all European citizens
Healthcare demand in China is an overwhelming challenge - stretched to the limit by the expectations of a newly empowered middle class and pressured by desperate, impoverished and indebted families
Accounting for 80% of China’s 10.3 million annual deaths (2005 data), chronic diseases such as cancer, diabetes, cardiovascular or respiratory diseases, will become a growing burden on the population and cause severe economic loss
Manufactured in a traditional way, by growing the inactivated virus, Valneva's vaccine could convince mRNA sceptics to reconsider and benefit from surging - and unmet - demand in developing countries, provided the firm scales production successfully
Chaos seems pre-ordained in FDA approval processes of numerous candidate vaccines. With a fluid reference to 'efficacy', the FDA is expected to deliver emergency authorizations within months, followed by rigorous and extensive year-long studies
"This time is different ", a reassuring promise or an optimistic prospect of a future yet unknown, popular consumption of cannabis might create massive growth markets, at the stroke of a federal regulatory pen...What if this time is different ?
The series draws attention to industry trends highlighting stock potential – and the headwinds battering investor optimism
With a small number of facilities in the US, the logistics of individual treatment – and their length – are likely to limit patient access and the pricing structures raise issues with vast implications for insurers and patients alike
The foundations of cancer treatment have been surgery, chemotherapy, radiation therapy and targeted therapies homing in on specific molecular changes seen primarily in cancer cells
The achievements of Fred Moll in medical robotics are close to legendary but the collaboration of Dr. Moll with Johnson & Johnson, may raise the bar, with real-time management of the data feeds informing the robotics applications - the next frontier...
Challenging dominant Intuitive Surgical, many robotics systems are coming to market but the vast ambitions of Auris Health stand out and Verb Surgical, a Google / Johnson & Johnson partnership, is waiting in the wings
When we heard that a group of do-it-yourself biologists was working to solve the insulin affordability problem by figuring out how to manufacture insulin patent-free, we got to know them
Diabetes is detected when the body can no longer regulate its own blood sugar levels. Blood sugar is controlled by insulin, a hormone made in the pancreas
To live up to the challenge and address the chronic diseases afflicting the population, biotech in China is committed for the long haul - R&D outcomes remain fickle and international license agreements get caught up in geopolitics
Already the largest drugs market after the US, with an aging population, more demanding patients and more combative families, China remains a tumultuous market place
Economies of scale in the production of generics through acquisitions may have been tactical responses in the industry, but TEVA's travails throw unforgiving light on on diverging worldwide strategies
